Actavis Buys Indian API Business

Generic pharmaceuticals manufacturer Actavis (Hafnarfjordur, Iceland) says it has acquired the active pharmaceutical ingredients (API) division of Sanmar Specialty Chemicals Ltd. (SSCL; Chennai, India). The acquisition price was not disclosed. Wessman: ‘Superior’ integration. The deal reinforces Actavis’s business in India, and completes the company’s pharma value chain in that country, Actavis says. Actavis has an API development facility and a contract research organization (CRO), Lotus Laboratories, at Bangalore. Lotus was acquired in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers